Physician profile
Alexa Summe
NPI 1184026551
$6,326.93
in general payments reported to CMS, 2019-2025
46 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $280 · 2021: $189 · 2022: $1,038 · 2023: $1,586 · 2024: $1,174 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,155.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,140.85 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $583.60 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $434.46 | 2019-2025 | Repatha, Evenity, Otezla |
| Pfizer INC. | $362.33 | 2019-2025 | |
| Lilly USA, LLC | $351.66 | 2020-2025 | Mounjaro, Jardiance, Emgality |
| Takeda Pharmaceuticals U.S.A., INC. | $294.03 | 2019-2025 | Trintellix, Gattex |
| Abbott Laboratories | $231.74 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.05 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $224.40 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $185.92 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $181.02 | 2019-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $175.29 | 2022-2024 | Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $170.61 | 2023 | Qelbree |
| Tris Pharma INC | $140.26 | 2022-2025 | Dyanavel Xr |
| Lundbeck LLC | $136.19 | 2022-2025 | Rexulti |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Summe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.